Maternally inherited PRKAR1A pathogenic variant causing Carney complex with a concomitant LDLR variant resulting in hyperlipidemia: a case report
- 1Department of Cardiology, Wuhan Asia Heart Hospital
Abstract
Objective: Carney complex (CNC) is an autosomal dominant multisystem tumor syndrome predominantly caused by pathogenic PRKAR1A mutations. Cardiac myxoma, multiple endocrine neoplasms and cutaneous pigmented lesions are its typical clinical manifestations. We report an extremely uncommon case of CNC caused by a PRKAR1A pathogenic variant, with a LDLR variant leading to familial hyperlipidemia and marked phenotypic heterogeneity within the family.
Case presentation: A 45-year-old male presented with palpitations was admitted to our hospital. The patient’s past medical history included cerebral infarction, myocardial infarction, right monocular blindness, and atrial myxoma. Physical examination revealed typical acromegalic facies, accompanied by markedly elevated serum growth hormone (GH) levels. Pituitary magnetic resonance imaging (MRI) further identified a pituitary neuroendocrine tumor. Transthoracic echocardiography and contrast-enhanced cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) demonstrated global cardiac chamber enlargement and ventricular hypertrophy. Coronary CTA revealed diffuse dilatation of the coronary artery. Genetic testing confirmed two maternally inherited pathogenic variants: the splice-donor variant PRKAR1A c.769 + 1G>A responsible for CNC, and LDLR c.1879G>A, which causes familial hypercholesterolemia. One month after discharge from our hospital, the patient received transnasal transsphenoidal resection of sellar pituitary lesion under general anesthesia at the Department of Neurosurgery in another general hospital. Preoperative GH and insulin-like growth factor 1 (IGF-1) were elevated on repeat testing, and both decreased significantly postoperatively. The sellar lesion was confirmed as a plurihormonal pituitary neuroendocrine tumor of pituitary transcription factor 1 (PIT-1) lineage; immunohistochemistry showed weak GH expression, focal prolactin (PRL) and luteinizing hormone (LH) expression, negative adrenocorticotropic hormone(ACTH) and T-box pituitary transcription factor(T-PIT) staining, with a Ki-67 labeling index of ~1%.
Conclusion: The splice-site variant PRKAR1A c.769 + 1G>A represents a well-documented recurrent pathogenic variant among patients with CNC. The majority of previously reported carriers develop primary pigmented nodular adrenocortical disease (PPNAD) and overt Cushing syndrome. However, our patient presented with acromegaly driven by a plurihormonal PIT-1-lineage pituitary neuroendocrine tumor without corticotroph differentiation. accompanied by atrial myxoma, cardiac hypertrophy, cardiomegaly, coronary dilatation, and familial hypercholesterolemia secondary to an LDLR mutation. This rare coexisting genetic phenotype underscores the value of prompt genetic and endocrine screening for at-risk patients.
Related
- Prenatal Diagnosis of Recurrent Fetal Intracranial Hemorrhage and a Maternally Inherited COL4A1 Variant of Uncertain Significance: A Case Report With Maternal Reverse Phenotyping
- Maternally Perceived Fetal Movement and Computerized Cardiotocography Parameters: What’s the Link? A Multicenter Pilot Study on Fetal Health
- Atorvastatin improves hyperlipidemia-induced erectile dysfunction via PKA-associated eNOS phosphorylation at the Ser633 site
- Causal effects between gut microbiology and hyperlipidemia : A 2-sample Mendelian randomization study
- Management of Hyperlipidemia: A Case Report.
BibTeX
@article{guo2026maternally,
title = {{Maternally inherited PRKAR1A pathogenic variant causing Carney complex with a concomitant LDLR variant resulting in hyperlipidemia: a case report}},
author = {Caihong Guo and Hongwei Yi and Yujing Yang and Caiping Han and Qingkun Fan and Jie Wang and Chenggang Deng},
journal = {Frontiers in Endocrinology},
year = {2026},
month = nov,
doi = {10.3389/fendo.2026.1966102},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1966102/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Maternally inherited PRKAR1A pathogenic variant causing Carney complex with a concomitant LDLR variant resulting in hyperlipidemia: a case report
AU - Caihong Guo
AU - Hongwei Yi
AU - Yujing Yang
AU - Caiping Han
AU - Qingkun Fan
AU - Jie Wang
AU - Chenggang Deng
PY - 2026
DA - 2026/11/05
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1966102
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1966102/full
AB - Objective: Carney complex (CNC) is an autosomal dominant multisystem tumor syndrome predominantly caused by pathogenic PRKAR1A mutations. Cardiac myxoma, multiple endocrine neoplasms and cutaneous pigmented lesions are its typical clinical manifestations. We report an extremely uncommon case of CNC caused by a PRKAR1A pathogenic variant, with a LDLR variant leading to familial hyperlipidemia and marked phenotypic heterogeneity within the family. Case presentation: A 45-year-old male presented with palpitations was admitted to our hospital. The patient’s past medical history included cerebral infarction, myocardial infarction, right monocular blindness, and atrial myxoma. Physical examination revealed typical acromegalic facies, accompanied by markedly elevated serum growth hormone (GH) levels. Pituitary magnetic resonance imaging (MRI) further identified a pituitary neuroendocrine tumor. Transthoracic echocardiography and contrast-enhanced cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) demonstrated global cardiac chamber enlargement and ventricular hypertrophy. Coronary CTA revealed diffuse dilatation of the coronary artery. Genetic testing confirmed two maternally inherited pathogenic variants: the splice-donor variant PRKAR1A c.769 + 1G>A responsible for CNC, and LDLR c.1879G>A, which causes familial hypercholesterolemia. One month after discharge from our hospital, the patient received transnasal transsphenoidal resection of sellar pituitary lesion under general anesthesia at the Department of Neurosurgery in another general hospital. Preoperative GH and insulin-like growth factor 1 (IGF-1) were elevated on repeat testing, and both decreased significantly postoperatively. The sellar lesion was confirmed as a plurihormonal pituitary neuroendocrine tumor of pituitary transcription factor 1 (PIT-1) lineage; immunohistochemistry showed weak GH expression, focal prolactin (PRL) and luteinizing hormone (LH) expression, negative adrenocorticotropic hormone(ACTH) and T-box pituitary transcription factor(T-PIT) staining, with a Ki-67 labeling index of ~1%. Conclusion: The splice-site variant PRKAR1A c.769 + 1G>A represents a well-documented recurrent pathogenic variant among patients with CNC. The majority of previously reported carriers develop primary pigmented nodular adrenocortical disease (PPNAD) and overt Cushing syndrome. However, our patient presented with acromegaly driven by a plurihormonal PIT-1-lineage pituitary neuroendocrine tumor without corticotroph differentiation. accompanied by atrial myxoma, cardiac hypertrophy, cardiomegaly, coronary dilatation, and familial hypercholesterolemia secondary to an LDLR mutation. This rare coexisting genetic phenotype underscores the value of prompt genetic and endocrine screening for at-risk patients.
SN - 1664-2392
ER -